Veterinary tech business bolsters international expansion with Seedrs and Global funding

London-based veterinary tech business, Felcana has received an early stage venture capital investment from Global Venture Partners and Seedrs.

The terms of the transaction have not been disclosed. Founded in 2016, Felcana combines artificial intelligence, data analytics and veterinary expertise to help predict, simplify and treat over 90 per cent of health issues for dogs and cats.

Felcana will use the fresh capital to expand its presence in the UK and to scale internationally. Felcana uses a bespoke modelling process that tracks and monitors the activity and behavioural patterns of individual pets, 24/7.

In sharing the personalised insights on a mobile/tablet app, the robust data not only helps owners to understand what is ‘normal’ for their pet, so that they can be more proactive in responding to their pet’s needs, but it also gives vets the data they need to provide more accurate diagnoses at the optimal time.

Using this innovative technology, Felcana will provide effective relief to conditions, such as arthritis, by helping to diagnose conditions at an earlier stage to minimise pain for the animal.

Spyro Korsanos, managing partner at Global Venture Partners, said: “Felcana is propelling pet care to the next digital level.

“A paradigm shift is already underway in human medicine and we see parallels in animal healthcare, with growing demand for personalised pet care. The ‘pet tech’ market is expected to reach $22 billion globally by 2025 and the propensity to spend on pet wellbeing is rising rapidly.”

“Global Venture Partners is excited to have the opportunity to support Felcana’s growth in the same way that we have helped some of Europe’s most successful consumer internet platforms to scale up.

“We’ll assist the team in driving growth across sales, marketing and international expansion.”